Skip to main content
. 2023 Dec 6;15(12):6821–6830. doi: 10.21037/jtd-23-1014

Table 2. Subjects’ outcomes between the two groups (x¯±s).

Group Standard group (n=74) HFNC group (n=77) t2/U P
NIV treatment duration (days) 5.93±4.02 4.22±2.12 −3.253 0.002
Length of stay in the ICU (days) 9.89±6.87 10.34±11.27 −0.292 0.771
Total length of hospital stay (days) 18.41±14.42 20.27±18.73 −0.679 0.498
Invasive ventilation duration (days) 2.70±5.97 2.35±10.74 0.247 0.805
Hospitalization expenses (yuan) 92,867.76±83,518.55 91,848.42±95,841.43 0.066 0.947
ROX index 3.79±0.41 4.63±0.59 10.190 <0.001
VAS 3.24±0.48 5.67±0.83 21.910 <0.001

HFNC, high-flow nasal cannula; NIV, non-invasive ventilation; ICU, intensive care unit; ROX, rate-oxygenation index; VAS, visual analogue scale.